Molecular Dynamics Simulations of the HIV-1 Integrase Dimerization Interface: Guidelines for the Design of a Novel Class of Integrase Inhibitors

被引:11
|
作者
Sippel, Martin [1 ]
Sotriffer, Christoph A. [1 ]
机构
[1] Julius Maximilians Univ Wuerzburg, Inst Pharm & Food Chem, D-97074 Wurzburg, Germany
关键词
PROTEIN-PROTEIN INTERACTIONS; VIRUS TYPE-1 INTEGRASE; PEPTIDE INHIBITORS; AUTOMATED DOCKING; GENETIC ALGORITHM; SCORING FUNCTION; BINDING MODES; LIGAND; DISCOVERY; RALTEGRAVIR;
D O I
10.1021/ci900403s
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
HIV-1 integrase (IN) is a validated target of anti-AIDS research. The classical approach of designing active-site directed ligands has largely been exploited. A promising alternative strategy to inactivate the enzyme is to prevent the formation of IN dimers. The rational design of dimerization inhibitors, however, is hampered by the lack of relevant structural data about the targeted monomeric form. Therefore, we performed molecular dynamics simulations and subsequent analyses to gain insight into the structural features of the IN catalytic-core-domain dimerization interface. As a result, the formation of a groove and a cavity along the dimerization interface of the IN monomer could be revealed. Both were shown to be suited for accommodating an inhibitory peptide. The results form a valuable basis for the design of ligands targeting the dimerization interface and, thus, of a whole new class of HIV-1 integrase inhibitors.
引用
收藏
页码:604 / 614
页数:11
相关论文
共 50 条
  • [11] Novel furocoumarins as potential HIV-1 integrase inhibitors
    Olomola, Temitope O.
    Mosebi, Salerwe
    Klein, Rosalyn
    Traut-Johnstone, Telisha
    Coates, Judy
    Hewer, Raymond
    Kaye, Perry T.
    BIOORGANIC CHEMISTRY, 2014, 57 : 1 - 4
  • [12] Novel, small molecule inhibitors of HIV-1 integrase
    Wu, J. J.
    Milot, G.
    Dandache, S.
    Gouveia, K.
    Xiao, Y.
    Yelle, J.
    Sevigny, G.
    Dubois, A.
    Tian, B.
    Perron, V.
    Herbart, D.
    Stranix, B. R.
    ANTIVIRAL THERAPY, 2007, 12 : S8 - S8
  • [13] Design of second generation HIV-1 integrase inhibitors
    Deng, Jinxia
    Dayam, Raveendra
    Al-Mawsawi, Laith Q.
    Neamati, Nouri
    CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (02) : 129 - 141
  • [14] Novel Inhibitors of Nuclear Translocation of HIV-1 Integrase
    Wagstaff, Kylie
    Rawlinson, Stephen
    Hearps, Anna
    Jans, David
    ANTIVIRAL RESEARCH, 2011, 90 (02) : A48 - A48
  • [15] Novel, small molecule inhibitors of HIV-1 integrase
    Wu, J. J.
    Milot, G.
    Dandache, S.
    Gouveia, K.
    Xiao, Y.
    Yelle, J.
    Sevigny, G.
    Dubois, A.
    Tian, B.
    Perron, V.
    Herbart, D.
    Stranix, B. R.
    ANTIVIRAL THERAPY, 2007, 12 (05) : S8 - S8
  • [16] A New Class of Multimerization Selective Inhibitors of HIV-1 Integrase
    Sharma, Amit
    Slaughter, Alison
    Jena, Nivedita
    Feng, Lei
    Kessl, Jacques J.
    Fadel, Hind J.
    Malani, Nirav
    Male, Frances
    Wu, Li
    Poeschla, Eric
    Bushman, Frederic D.
    Fuchs, James R.
    Kvaratskhelia, Mamuka
    PLOS PATHOGENS, 2014, 10 (05)
  • [17] The future of integrase inhibitors of HIV-1
    Malet, Isabelle
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    CURRENT OPINION IN VIROLOGY, 2012, 2 (05) : 580 - 587
  • [18] The hunt for HIV-1 integrase inhibitors
    Lataillade, Max
    Kozal, Michael J.
    AIDS PATIENT CARE AND STDS, 2006, 20 (07) : 489 - 501
  • [19] Arylamide inhibitors of HIV-1 integrase
    Zhao, H
    Neamati, N
    Mazumder, A
    Sunder, S
    Pommier, Y
    Burke, TR
    JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (08) : 1186 - 1194
  • [20] Thiazolothiazepine inhibitors of HIV-1 integrase
    Neamati, N
    Turpin, JA
    Winslow, HE
    Christensen, JL
    Williamson, K
    Orr, A
    Rice, WG
    Pommier, Y
    Garofalo, A
    Brizzi, A
    Campiani, G
    Fiorini, I
    Nacci, V
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (17) : 3334 - 3341